| Recognition of Stage-Specific Mycobacterial Antigens Differentiates between Acute and Latent Infections with Mycobacterium tuberculosis A Demissie, EMS Leyten, M Abebe, L Wassie, A Aseffa, G Abate, ... Clinical and vaccine immunology 13 (2), 179-186, 2006 | 269 | 2006 |
| Large-Scale Evaluation of Enzyme-Linked Immunospot Assay and Skin Test for Diagnosis of Mycobacterium tuberculosis Infection against a Gradient of Exposure … PC Hill, RH Brookes, A Fox, K Fielding, DJ Jeffries, D Jackson-Sillah, ... Clinical Infectious Diseases 38 (7), 966-973, 2004 | 246 | 2004 |
| Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries: issues in study design HB Ibanga, RH Brookes, PC Hill, PK Owiafe, HA Fletcher, C Lienhardt, ... The Lancet Infectious Diseases 6 (8), 522-528, 2006 | 94 | 2006 |
| Quantitative T Cell Assay Reflects Infectious Load of Mycobacterium tuberculosis in an Endemic Case Contact Model PC Hill, A Fox, DJ Jeffries, D Jackson-Sillah, MD Lugos, PK Owiafe, ... Clinical infectious diseases 40 (2), 273-278, 2005 | 93 | 2005 |
| Increased expression of mRNA encoding interleukin (IL)‐4 and its splice variant IL‐4δ2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation HA Fletcher, P Owiafe, D Jeffries, P Hill, GAW Rook, A Zumla, TM Doherty, ... Immunology 112 (4), 669-673, 2004 | 90 | 2004 |
| Efficacy of a novel, protein-based pneumococcal vaccine against nasopharyngeal carriage of Streptococcus pneumoniae in infants: A phase 2, randomized … A Odutola, MOC Ota, M Antonio, EO Ogundare, Y Saidu, E Foster-Nyarko, ... Vaccine 35 (19), 2531-2542, 2017 | 85 | 2017 |
| Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa RH Brookes, PC Hill, PK Owiafe, HB Ibanga, DJ Jeffries, SA Donkor, ... PLoS One 3 (8), e2921, 2008 | 83 | 2008 |
| Interferon-γ ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial IM Adetifa, MOC Ota, DJ Jeffries, MD Lugos, AS Hammond, NJ Battersby, ... American journal of respiratory and critical care medicine 187 (4), 439-445, 2013 | 72 | 2013 |
| Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants MOC Ota, AA Odutola, PK Owiafe, S Donkor, OA Owolabi, NJ Brittain, ... Science translational medicine 3 (88), 88ra56-88ra56, 2011 | 66 | 2011 |
| Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine when given as a booster to BCG in Gambian infants: an open-label randomized controlled trial OT Idoko, OA Owolabi, PK Owiafe, P Moris, A Odutola, A Bollaerts, ... Tuberculosis 94 (6), 564-578, 2014 | 61 | 2014 |
| Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2–4 years: A phase II randomized study A Odutola, MO Ota, EO Ogundare, M Antonio, P Owiafe, A Worwui, ... Human vaccines & immunotherapeutics 12 (2), 393-402, 2016 | 44 | 2016 |
| Elevated serum 25-hydroxy (OH) vitamin D levels are associated with risk of TB progression in Gambian adults O Owolabi, S Agbla, P Owiafe, S Donkor, T Togun, AK Sillah, MOC Ota, ... Tuberculosis 98, 86-91, 2016 | 30 | 2016 |
| A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants AA Odutola, OA Owolabi, PK Owiafe, H McShane, MOC Ota Vaccine 30 (38), 5591-5594, 2012 | 30 | 2012 |
| ESAT-6 and CFP-10 can be combined to reduce the cost of testing for Mycobacterium tuberculosis infection, but CFP-10 responses associate with active disease A Fox, DJ Jeffries, PC Hill, AS Hammond, MD Lugos, D Jackson-Sillah, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 101 (7 …, 2007 | 27 | 2007 |
| Broad Adaptive Immune Responses to M. tuberculosis Antigens Precede TST Conversion in Tuberculosis Exposed Household Contacts in a TB-Endemic Setting UK Buchwald, IMO Adetifa, C Bottomley, PK Owiafe, S Donkor, AL Bojang, ... PLoS One 9 (12), e116268, 2014 | 24 | 2014 |
| Immunogenicity of pneumococcal conjugate vaccine formulations containing pneumococcal proteins, and immunogenicity and reactogenicity of co-administered routine vaccines–A … A Odutola, MOC Ota, M Antonio, EO Ogundare, Y Saidu, PK Owiafe, ... Vaccine 37 (19), 2586-2599, 2019 | 22 | 2019 |
| Haematological and biochemical reference values of G ambian infants AA Odutola, MO Afolabi, J Jafali, I Baldeh, OA Owolabi, P Owiafe, G Bah, ... Tropical medicine & international health 19 (3), 275-283, 2014 | 20 | 2014 |
| Immunogenic Mycobacterium africanum strains associated with ongoing transmission in The Gambia F Gehre, M Antonio, JK Otu, N Sallah, O Secka, T Faal, P Owiafe, ... Emerging infectious diseases 19 (10), 1593, 2013 | 16 | 2013 |
| The effect of tuberculin skin test and BCG vaccination on the expansion of PPD-specific IFN-γ producing cells ex vivo MOC Ota, RH Brookes, PC Hill, PK Owiafe, HB Ibanga, S Donkor, T Awine, ... Vaccine 25 (52), 8861-8867, 2007 | 15 | 2007 |
| Mycobacterium tuberculosis infection in close childhood contacts of adults with pulmonary tuberculosis is increased by secondhand exposure to tobacco IMO Adetifa, L Kendall, S Donkor, MD Lugos, AS Hammond, PK Owiafe, ... The American journal of tropical medicine and hygiene 97 (2), 429, 2017 | 12 | 2017 |
